Evidence map›Paper›PMID 35054039›Full record

ArticleJournal of clinical medicine2022

Feasibility of Combining Transcranial Direct Current Stimulation and Active Fully Embodied Virtual Reality for Visual Height Intolerance: A Double-Blind Randomized Controlled Study.

Samuel Bulteau, Andrew Laurin, Kalyane Bach-Ngohou, Morgane Péré, Marie-Anne Vibet, Jean-Benoit Hardouin, Véronique Sebille, Lydie Lagalice, Élodie Faurel-Paul, Didier Acier and 8 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Samuel BulteauDepartment of Addictology and Consultation-Liaison Psychiatry, CHU Nantes, F-44000 Nantes, France.
Andrew LaurinDepartment of Addictology and Consultation-Liaison Psychiatry, CHU Nantes, F-44000 Nantes, France.ORCID 0000-0002-7806-961X
Kalyane Bach-NgohouThe Enteric Nervous System in Gut and Brain Disorders, INSERM, IMAD, Department of Biology, Laboratory of Clinical Biochemistry, and TENS, CHU Nantes, F-44000 Nantes, France.
Morgane PéréDepartment of Methodology and Biostatistics, CHU Nantes, F-44000 Nantes, France.
Marie-Anne VibetDepartment of Methodology and Biostatistics, CHU Nantes, F-44000 Nantes, France.
Jean-Benoit HardouinFrench Institute of Health and Medical Research (INSERM), UMR 1246 SPHERE, Université of Nantes, F-44000 Nantes, France.
Véronique SebilleFrench Institute of Health and Medical Research (INSERM), UMR 1246 SPHERE, Université of Nantes, F-44000 Nantes, France.
Lydie LagaliceDepartment of Addictology and Consultation-Liaison Psychiatry, CHU Nantes, F-44000 Nantes, France.
Élodie Faurel-PaulDepartment of Promotion, CHU Nantes, F-44000 Nantes, France.
Didier AcierDepartment of Psychology, University of Nantes, F-44312 Nantes, France.
Thomas RabeyronDepartment of Psychology, University of Lorraine, Interpsy, F-54000 Nancy, France.
Valéry-Pierre RicheEconomic Evaluation and Health Products Development Service, Partnership and Innovation Department, CHU Nantes, F-44000 Nantes, France.
Anne SauvagetDepartment of Addictology and Consultation-Liaison Psychiatry, CHU Nantes, F-44000 Nantes, France.
Florian MelkiLS2N-UMR 6004 CNRS, University of Nantes, F-44000 Nantes, France.
Toinon VigierLS2N-UMR 6004 CNRS, University of Nantes, F-44000 Nantes, France.
Matthieu Perreira Da SilvaLS2N-UMR 6004 CNRS, University of Nantes, F-44000 Nantes, France.ORCID 0000-0003-3921-5132
Olivier CharletDepartment of Psychology, University of Lorraine, Interpsy, F-54000 Nancy, France.
Yannick PriéLS2N-UMR 6004 CNRS, University of Nantes, F-44000 Nantes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTranscranial Direct Current Stimulation (tDCS) and Virtual Reality Exposure Therapy (VRET) are individually increasingly used in psychiatric research. OBJECTIVE/HYPOTHESIS: Our study aimed to investigate the feasibility of combining tDCS and wireless 360° full immersive active and embodied VRET to reduce height-induced anxiety.

methodsWe carried out a pilot randomized, double-blind, controlled study associating VRET (two 20 min sessions with a 48 h interval, during which, participants had to cross a plank at rising heights in a building in construction) with online tDCS (targeting the ventromedial prefrontal cortex) in 28 participants. The primary outcomes were the sense of presence level and the tolerability. The secondary outcomes were the anxiety level (Subjective Unit of Discomfort) and the salivary cortisol concentration.

resultsWe confirmed the feasibility of the association between tDCS and fully embodied VRET associated with a good sense of presence without noticeable adverse effects. In both groups, a significant reduction in the fear of height was observed after two sessions, with only a small effect size of add-on tDCS (0.1) according to the SUD. The variations of cortisol concentration differed in the tDCS and sham groups.

conclusionOur study confirmed the feasibility of the association between wireless online tDCS and active, fully embodied VRET. The optimal tDCS paradigm remains to be determined in this context to increase effect size and then adequately power future clinical studies assessing synergies between both techniques.

Indexed as

anxietytherapytranscranial direct current stimulationtreatmentvirtual realityvisual height intolerance

Identifiers

PMID35054039
PMCPMC8779186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.